{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:02:20Z","timestamp":1780588940508,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100030702","name":"Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["FMM22\/01"],"award-info":[{"award-number":["FMM22\/01"]}],"id":[{"id":"10.13039\/100030702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37430-0","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:14:58Z","timestamp":1770995698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the efficiency of combined antiviral therapy in COVID-19 challenging immunocompromised patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Marta","family":"L\u00f3pez-Llar\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Tejerina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Regalado-Artamendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Veintimilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Mesones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Perez Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fanciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Aldamiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"P\u00e9rez-Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar\u00edo","family":"Garc\u00eda de Viedma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Gregorio Mara\u00f1\u00f3n Microbiology-ID COVID 19 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcal\u00e1","family":"Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ald\u00e1miz","family":"Teresa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvarez-Ur\u00eda","family":"Ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berm\u00fadez","family":"Elena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouza","family":"Emilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buenestado-Serrano","family":"Sergio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burillo","family":"Almudena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catal\u00e1n","family":"Pilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cercenado","family":"Emilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00edez","family":"Cristina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Escribano","family":"Pilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Est\u00e9vez","family":"Agust\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanciulli","family":"Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galar","family":"Alicia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garc\u00eda","family":"M\u00aa Dolores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garc\u00eda de Viedma","family":"Dar\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guinea","family":"Jes\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herranz","family":"Marta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irigoyen","family":"\u00c1lvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kestler","family":"Martha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00f3pez","family":"Juan Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machado","family":"Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edn","family":"Mercedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn-Rabad\u00e1n","family":"Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molero-Salinas","family":"Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montilla","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu\u00f1oz","family":"Patricia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palomo","family":"Mar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9rez-Granda","family":"Mar\u00eda Jes\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9rez-Lago","family":"Laura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9rez","family":"Leire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reigadas","family":"Elena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinc\u00f3n","family":"Cristina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodr\u00edguez","family":"Bel\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodr\u00edguez","family":"Sara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rojas","family":"Adriana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiz-Serrano","family":"Mar\u00eda Jes\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1nchez","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanz-P\u00e9rez","family":"Amadeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serrano","family":"Julia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejerina","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Maricela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veintimilla","family":"M\u00aa Cristina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesperinas","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Teresa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"de la Villa","family":"Sof\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"37430_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01177-0","volume":"14","author":"L Pagano","year":"2021","unstructured":"Pagano, L. et al. COVID-19 infection in adult patients with hematological malignancies: A European Hematology Association Survey (EPICOVIDEHA). J. Hematol. Oncol. 14, 1\u201315 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"37430_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/QCO.0000000000000841","volume":"35","author":"JC Laracy","year":"2022","unstructured":"Laracy, J. C., Kamboj, M. & Vardhana, S. A. Long and persistent COVID-19 in patients with hematologic malignancies: From bench to bedside. Curr. Opin Infect. Dis. 35, 271\u2013279 (2022).","journal-title":"Curr. Opin Infect. Dis."},{"key":"37430_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1158\/2159-8290.CD-21-1033","volume":"12","author":"CY Lee","year":"2022","unstructured":"Lee, C. Y. et al. Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies. Cancer Discov. 12, 62\u201373 (2022).","journal-title":"Cancer Discov."},{"key":"37430_CR4","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s00277-021-04656-z","volume":"100","author":"R Arcani","year":"2021","unstructured":"Arcani, R. et al. Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue. Ann. Hematol. 100, 2799\u20132803 (2021).","journal-title":"Ann. Hematol."},{"key":"37430_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMsb2104756","volume":"385","author":"L Corey","year":"2021","unstructured":"Corey, L. et al. SARS-CoV-2 variants in patients with immunosuppression. N. Engl. J. Med. 385, 562\u2013566 (2021).","journal-title":"N. Engl. J. Med."},{"key":"37430_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","volume":"21","author":"MG Cox","year":"2022","unstructured":"Cox, M. G. et al. SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. Nat. Rev. Microbiol. 21, 112\u2013124 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"37430_CR7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s40265-023-01926-0","volume":"83","author":"HA Blair","year":"2023","unstructured":"Blair, H. A. Remdesivir: A review in COVID-19. Drugs 83, 1215\u20131237 (2023).","journal-title":"Drugs"},{"key":"37430_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","volume":"11","author":"TP Sheahan","year":"2020","unstructured":"Sheahan, T. P. et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Commun. 11, 1\u201314 (2020).","journal-title":"Nat. Commun."},{"key":"37430_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.cmi.2022.04.018","volume":"28","author":"TC Lee","year":"2022","unstructured":"Lee, T. C. et al. Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. Clin. Microbiol. Infect. 28, 1203\u20131210 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"37430_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/v16020217","volume":"16","author":"D Focosi","year":"2024","unstructured":"Focosi, D., Casadevall, A., Franchini, M. & Maggi, F. Sotrovimab: A review of its efficacy against SARS-CoV-2 variants. Viruses 16, 217 (2024).","journal-title":"Viruses"},{"key":"37430_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(22)00365-6","volume":"22","author":"D Yamasoba","year":"2022","unstructured":"Yamasoba, D. et al. Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies. Lancet Infect. Dis. 22, 942\u2013943 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"37430_CR12","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","volume":"59","author":"T Pillaiyar","year":"2016","unstructured":"Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y. & Jung, S. H. An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy. J. Med. Chem. 59, 6595\u20136628 (2016).","journal-title":"J. Med. Chem."},{"issue":"374","key":"37430_CR13","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"1979","author":"DR Owen","year":"2021","unstructured":"Owen, D. R. et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science 1979(374), 1586\u20131593 (2021).","journal-title":"Science"},{"key":"37430_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015395.pub3","author":"S Reis","year":"2023","unstructured":"Reis, S. et al. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD015395.pub3 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"37430_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41586-021-03312-w","volume":"591","author":"A Wahl","year":"2021","unstructured":"Wahl, A. et al. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature 591, 451 (2021).","journal-title":"Nature"},{"key":"37430_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N. Engl. J. Med. 386, 1397\u20131408 (2022).","journal-title":"N. Engl. J. Med."},{"key":"37430_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb, R. L. et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N. Engl. J. Med. 386, 305\u2013315 (2022).","journal-title":"N. Engl. J. Med."},{"key":"37430_CR18","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","volume":"385","author":"A Gupta","year":"2021","unstructured":"Gupta, A. et al. Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab. N. Engl. J. Med. 385, 1941\u20131950 (2021).","journal-title":"N. Engl. J. Med."},{"key":"37430_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/joim.20030","volume":"297","author":"I Mastrorosa","year":"2025","unstructured":"Mastrorosa, I. et al. Incidence and predictors of clinical failure after early treatment for mild-to-moderate COVID-19 in high-risk individuals: A multicentric cohort study. J Intern Med 297, 328\u2013334 (2025).","journal-title":"J Intern Med"},{"key":"37430_CR20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cmi.2024.04.009","volume":"30","author":"SE Meijer","year":"2024","unstructured":"Meijer, S. E. et al. Persistent COVID-19 in immunocompromised patients\u2014Israeli society of infectious diseases consensus statement on diagnosis and management. Clin. Microbiol. Infect. 30, 1012\u20131017 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"37430_CR21","doi-asserted-by":"publisher","first-page":"e03331-22","DOI":"10.1128\/spectrum.03331-22","volume":"10","author":"J Wagoner","year":"2022","unstructured":"Wagoner, J. et al. Combinations of host- and virus-targeting antiviral drugs confer synergistic suppression of SARS-CoV-2. Microbiol. Spectr. 10, e03331-22 (2022).","journal-title":"Microbiol. Spectr."},{"key":"37430_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/QCO.0000000000001070","volume":"37","author":"C Sepulcri","year":"2024","unstructured":"Sepulcri, C., Bartalucci, C. & Mikulska, M. Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients. Curr. Opin Infect. Dis. 37, 506\u2013517 (2024).","journal-title":"Curr. Opin Infect. Dis."},{"key":"37430_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/cid\/ciad181","volume":"77","author":"M Mikulska","year":"2023","unstructured":"Mikulska, M. et al. Triple combination therapy with 2 antivirals and monoclonal antibodies for persistent or relapsed severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients. Clin. Infect. Dis. 77, 280\u2013286 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"37430_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-024-09466-y","volume":"24","author":"S Rotundo","year":"2024","unstructured":"Rotundo, S. et al. Early initiation of combined therapy in severely immunocompromised patients with COVID-19: A retrospective cohort study. BMC Infect. Dis. 24, 1\u20137 (2024).","journal-title":"BMC Infect. Dis."},{"key":"37430_CR25","first-page":"1","volume":"22","author":"V Scaglione","year":"2022","unstructured":"Scaglione, V. et al. Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: A retrospective study. BMC Infect. Dis. 22, 1\u201317 (2022).","journal-title":"BMC Infect. Dis."},{"key":"37430_CR26","doi-asserted-by":"publisher","unstructured":"Antonello, R. M. et al. Antiviral combination regimens as rescue therapy in immunocompromised hosts with persistent COVID-19. J. Chemother. https:\/\/doi.org\/10.1080\/1120009X.2024.2367935 (2025) https:\/\/doi.org\/10.1080\/1120009X.2024.2367935.","DOI":"10.1080\/1120009X.2024.2367935"},{"key":"37430_CR27","doi-asserted-by":"publisher","unstructured":"Horby, P. W. et al. Sotrovimab versus usual care in patients admitted to hospital with COVID-19: A randomised, controlled, open-label, platform trial (RECOVERY). medRxiv 2025.01.24.25321081 (2025) https:\/\/doi.org\/10.1101\/2025.01.24.25321081.","DOI":"10.1101\/2025.01.24.25321081"},{"key":"37430_CR28","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1093\/cid\/ciac601","volume":"76","author":"S Huygens","year":"2023","unstructured":"Huygens, S., Oude Munnink, B., Gharbharan, A., Koopmans, M. & Rijnders, B. Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the severe acute respiratory syndrome coronavirus 2 omicron variant. Clin. Infect. Diseases 76, e507\u2013e509 (2023).","journal-title":"Clin. Infect. Diseases"},{"key":"37430_CR29","doi-asserted-by":"publisher","first-page":"107095","DOI":"10.1016\/j.ijantimicag.2024.107095","volume":"63","author":"J Calder\u00f3n-Parra","year":"2024","unstructured":"Calder\u00f3n-Parra, J. et al. Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy versus monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study. Int. J. Antimicrob. Agents 63, 107095 (2024).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"37430_CR30","unstructured":"Susceptibility summaries - Table 1 - mAb vs variants\/mutations wt - Stanford Coronavirus Antiviral & Resistance Database (CoVDB). https:\/\/covdb.stanford.edu\/susceptibility-data\/table-mab-susc\/."},{"key":"37430_CR31","doi-asserted-by":"publisher","first-page":"e00266","DOI":"10.1128\/aac.00266-23","volume":"67","author":"R Palomino-Cabrera","year":"2023","unstructured":"Palomino-Cabrera, R. et al. Frequent emergence of resistance mutations following complex intra-host genomic dynamics in SARS-CoV-2 patients receiving sotrovimab. Antimicrob. Agents Chemother. 67, e00266-e323 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"37430_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/cid\/ciad494","volume":"78","author":"NS Zuckerman","year":"2024","unstructured":"Zuckerman, N. S., Bucris, E., Keidar-Friedman, D., Amsalem, M. & Brosh-Nissimov, T. Nirmatrelvir Resistance\u2014de Novo E166V\/L50V Mutations in an Immunocompromised Patient Treated With Prolonged Nirmatrelvir\/Ritonavir Monotherapy Leading to Clinical and Virological Treatment Failure\u2014A Case Report. Clin. Infect. Dis. 78, 352\u2013355 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"37430_CR33","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/cid\/ciab700","volume":"74","author":"J Calder\u00f3n-Parra","year":"2022","unstructured":"Calder\u00f3n-Parra, J. et al. Incidence, clinical presentation, relapses and outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients treated with anti-CD20 monoclonal antibodies. Clin. Infect. Dis. 74, 1786\u20131794 (2022).","journal-title":"Clin. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37430-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:25:17Z","timestamp":1780586717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37430-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37430"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37430-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethical Committe of Gregorio Mara\u00f1\u00f3n Hospital (Ref\n                      MICRO.HGUGM.2022\u2013013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17372"}}